Skip to main content

Prostate and Urologic Cancers

Conducts and supports research on the prevention and early detection of prostate and bladder cancers. Develops and supports prevention trials and evaluation of new agents, surrogate biomarkers, and emerging technologies for identifying premalignant lesions.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Asefa, Mela mela.asefa@nih.gov 240-276-6422	5E328	Program Support Assistant \| Breast and Gynecologic Cancer Program Support Assistant \| Prostate and Urologic Cancer
	House, Margaret, RN, B.S.N. margaret.house@nih.gov 240-276-7047	5E306	Deputy Chief \| Prostate and Urologic Cancer
	Parnes, Howard L., M.D. howard.parnes@nih.gov 240-276-7045	5E302	Chief \| Prostate and Urologic Cancer

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Sears, Rosalie C	Oregon Health & Science University United States	An atlas of pancreatic tumorigenesis in the context of altered DNA repair occurring in high-risk individuals	4U01CA294548-02	Indu Kohaar, Ph.D., M.Phil., M.Sc.
Sears, Rosalie C	Oregon Health & Science University United States	Validation of novel imaging and molecular tests for early detection of pancreatic cancer through risk-stratified community engagement programs	5U01CA278923-03	Matthew Young, Ph.D.
Sedrak, Mina S	University Of California Los Angeles United States	Targeting Senescence to Mitigate Chemotherapy-induced Functional Decline	5R01CA280088-03	Goli Samimi, Ph.D., M.P.H.
Segal, Leopoldo Nicolas	New York University School Of Medicine United States	Microbial and host biomarker development for detection and prognosis of early stage non-small cell lung cancer	5U2CCA271890-03	Guillermo Marquez, Ph.D.
Segata, Nicola	University Of Trento United States	PROSPECT - Microbiome Studies. (PATHWAYS, RISK FACTORS, AND MOLECULES TO PREVENT EARLY-ONSET COLORECTAL TUMOURS)	1OT2CA297205-01	Asad Umar, D.V.M., Ph.D.
Seguin-Fowler, Rebecca Anne	Texas A&M Agrilife Research United States	Deep in the Heart for Women: A Community-Engaged Intervention Study to Catalyze a Culture of Health in Rural South Texas	1R01HL179449-01	Goli Samimi, Ph.D., M.P.H.
Semmes, Oliver John	Old Dominion University United States	Virginia-UCLA-Toronto Biomarker Characterization Center	5U2CCA271894-05	Indu Kohaar, Ph.D., M.Phil., M.Sc.
Sempere, Lorenzo	Michigan State University United States	Image-Guided Intraductal Ablative Procedure for Primary Prevention of Breast Cancer	5R01CA258314-04	Edward Sauter, M.D., Ph.D.
Sen, Subrata	University Of Tx Md Anderson Can Ctr United States	Circulating Biomarkers and Imaging for Early Detection of Pancreatic Cancer	5U01CA214263-07	Matthew Young, Ph.D.
Shah, Sohrab P	Sloan-Kettering Inst Can Research United States	Exploiting markers of genomic instability in high-risk pre-invasive ovarian cancer	5R01CA281928-03	Christos Patriotis, Ph.D., M.Sc.
Shain, Alan Hunter	University Of California, San Francisco United States	Pre-cancer atlas of skin cancer	4U01CA294536-02	Nicholas Hodges, Ph.D.
Shalon, Tidhar Dari	Envivo Bio Inc United States	Development and clinical evaluation of the CapScan gastrointestinal sampling device for metabolomics monitoring	5R33CA260665-04	Amit Kumar, Ph.D.
Shelby, Rebecca A	Duke University United States	Improving outcomes for women experiencing premature or early menopause after cancer: development and pilot testing of a novel intervention	1R21CA301298-01	Goli Samimi, Ph.D., M.P.H.
Shelby, Rebecca A	Duke University United States	Persistent Post-Mastectomy Pain: Randomized Clinical Trial of Targeted Pain Coping Skills Training (Targeted-PCST) with Mediational Analysis	5R01CA249959-05	Brennan Streck, Ph.D., RN, M.P.H.
Shiozawa, Yusuke	Wake Forest University Health Sciences United States	Contribution of cutaneous neuro-immune interactions to chemotherapy-induced peripheral neuropathy	1R21CA297068-01	Rachel Altshuler, Ph.D.